Clinical and Applied Thrombosis/Hemostasis (Jan 2022)

Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism

  • Darko Antic MD, PhD,
  • Eleftheria Lefkou MD, PhD,
  • Vladimir Otasevic MD,
  • Ljiljana Banfic MD, PhD,
  • Evangelos Dimakakos MD, PhD,
  • Dan Olinic MD, PhD,
  • Dragan Milić MD, PhD,
  • Predrag Miljić MD, PhD,
  • Sokol Xhepa MD, PhD,
  • Igor Stojkovski MD, PhD,
  • Matija Kozak MD, PhD,
  • Doina Ruxandra Dimulescu MD, PhD,
  • Tamara Kovačević Preradović MD, PhD,
  • Jasminka Nancheva MD, PhD,
  • Evelina Evtimova Pazvanska MD, PhD,
  • Gregor Tratar MD, PhD,
  • Grigoris T. Gerotziafas MD, PhD

DOI
https://doi.org/10.1177/1076029620939181
Journal volume & issue
Vol. 28

Abstract

Read online

Venous thromboembolism (VTE) is a multifactorial disease that can possibly affect any part of venous circulation. The risk of VTE increases by about 2 fold in pregnant women and VTE is one of the major causes of maternal morbidity and mortality. For decades superficial vein thrombosis (SVT) has been considered as benign, self-limiting condition, primarily local event consequently being out of scope of well conducted epidemiological and clinical studies. Recently, the approach on SVT has significantly changed considering that prevalence of lower limb SVT is twice higher than both deep vein thrombosis (DVT) and pulmonary embolism (PE). The clinical severity of SVT largely depends on the localization of thrombosis, when it concerns the major superficial vein vessels of the lower limb and particularly the great saphenous vein. If untreated or inadequately treated, SVT can potentially cause DVT or PE. The purpose of this review is to discuss the complex interconnection between SVT and risk factors in pregnancy and to provide evidence-based considerations, suggestions, and recommendations for the diagnosis and treatment of this precarious and delicate clinical entity.